Last edition
News about "Mucinex 12HR Cold and Fever Multi-Symptom"
Reckitt Secures FDA Approval for First OTC Cold and Flu Innovation in 14 Years
Reckitt has received U.S. FDA approval for Mucinex 12HR Cold and Fever Multi-Symptom, marking the first over-the-counter cold and flu innovation approved in 14 years. The product combines three active ingredients in a first-of-its-kind bilayer tablet designed to deliver extended relief for multiple cold and flu symptoms.
Mucinex 12HR Cold And Fever Multi-Symptom | 06/08/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy